Cargando…
Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia
BACKGROUND: We have previously demonstrated that a pooled population of bone marrow-derived, allogeneic mesenchymal stromal cells (BMMSC), Stempeucel®-1, produced under good manufacturing practices (GMP) conditions, showed clinical efficacy and safety in patients suffering from critical limb ischemi...
Autores principales: | Thej, Charan, Balasubramanian, Sudha, Rengasamy, Mathiyazhagan, Walvekar, Ankita, Swamynathan, Priyanka, Raj, Swathi Sundar, Shahani, Pradnya, Siddikuzzaman, Kolkundkar, Udaykumar, Seetharam, Raviraja N., Gupta, Pawan Kumar, Majumdar, Anish S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108338/ https://www.ncbi.nlm.nih.gov/pubmed/33971964 http://dx.doi.org/10.1186/s13287-021-02330-9 |
Ejemplares similares
-
Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2016) -
Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product
por: Thej, Charan, et al.
Publicado: (2017) -
Administration of Adult Human Bone Marrow‐Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger’s Disease: Phase II Study Report Suggests Clinical Efficacy
por: Gupta, Pawan K., et al.
Publicado: (2016) -
Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint
por: Gupta, Pawan Kumar, et al.
Publicado: (2016) -
Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2017)